| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Feb―15 |
COVID-19 Impact on Lipid Profile and Metabolome in Patients with Type 2 Diabetes Mellitus: Mini-Review |
Karolina Pawłuszkiewicz, Anita Maria Faltus, Gabriela Augustynowicz, Zofia Bielenin, Agnieszka Bronowicka-Szydełko, Katarzyna Madziarska, et al. (+3) Emil Paluch, Barbara Porębska, Joanna Kluz |
| 2 |
[GO] |
2025―Jan―28 |
Unraveling the Mystery: COVID-19 and Diabetic Complications - A Journey from Pathophysiology to Treatment |
Muhammed Amanat, Sapna Tandon, Randhir Singh |
| 3 |
[GO] |
2024―Oct―03 |
The Effect of COVID-19 Lockdown Among Adolescents with Type 1 Diabetes: A Systematic Review and Meta-Analysis |
Aaliyah Momani, Aram Halimi, Seyed Saeed Hashemi Nazari, Zalikha Al-Marzouqi, Alireza Mosavi Mosavi Jarrahi, Nabeel Al-Yateem, et al. (+2) Syed Azizur Rahman, Amina Al-Marzouqi |
| 4 |
[GO] |
2024―Feb―28 |
Recent Patterns and Assessment of Long-term Complications following SARS-CoV-2 Infection and Vaccination in the Context of Diabetes
Prevalence among Blood Donors |
Turki Mohammed M Alqahtani, Mohammed Abdullah Ali Alghamdi, Mirza Rafi Baig, Fahad A. Al-Abbasi, Rizwan Shiek, Sultan Alhayyani, et al. (+3) Turky Omar Asar, Firoz Anwar, Vikas Kumar |
| 5 |
[GO] |
2023―Apr―27 |
Microbial crosstalk between SARS-CoV-2 and Diabetes Mellitus - A Mini Review |
Supriya Kheur, Sushmita Ghosal, Karishma Madhusudan Desai |
| 6 |
[GO] |
2022―Oct―18 |
Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management |
Natalia Vallianou |
| 7 |
[GO] |
2022―Sep―14 |
COVID-19 & Diabetes Mellitus: Mutual Interplay of Two Diseases |
Gabriel Minárik, Patrik Krumpolec, Dominik Kodada, Nikola Nyariova, Vanda Repiska |
| 8 |
[GO] |
2022―Aug―27 |
Diabetic Patients with COVID-19 Complications: Insights into Prevalence, Prognosis, Combination Medications, and Underlying Mechanisms |
Pranay Wal, Jyotsana Dwivedi, Ankita Wal, Shivangi Kushwaha |
| 9 |
[GO] |
2022―Aug―23 |
Anxiety, Depression, and Fear among People with and without Diabetes During the Transmission of SARS-CoV-2 Omicron Variant |
Asirvatham Alwin Robert, Abdulrahman Al Dawish, Raseel Mohammed Al Dawish, Safa Muqhim Al Mutairi, Maryam Salem Alanazi, Mohamed Abdulaziz Al Dawish |
| 10 |
[GO] |
2022―Jul―31 |
Diabetes Mellitus and SARS-CoV-2 Infection: Pathophysiologic Mechanisms and Implications in Management. |
Natalia G Vallianou |
| 11 |
[GO] |
2022―Jun―13 |
Psychological Outcomes of the COVID-19 Pandemic on People with Type 1 Diabetes Globally: A Scoping Review |
Jennifer L. Maizel, Brittney N. Dixon, Ashby F. Walker |
| 12 |
[GO] |
2022―Apr―27 |
Colostrum Antibodies and Cytokines in Puerperal Women with Diabetes Before and During the COVID-19 Pandemic: A Systematic Review |
Rosane Nassar Meireles Guerra, Cláudia Regina Silva dos Santos Cunha, Marcela Patrícia Macêdo Belo Fort, Eremita Val Rafael, Rebeca Aranha Arrais e Silva Santos, Mônica Virginia Viegas Lima-Aragão, et al. (+2) Mayara Cristina Pinto Silva, Flávia Raquel Fernandes Nascimento |
| 13 |
[GO] |
2022―Apr―12 |
The Insights on Why Diabetes Prevalence May Increase Amid or Post COVID 19 Pandemic |
Ntethelelo Sibiya, Nomusa Mzimela, Bonisiwe Mbatha, Phikelelani Ngubane, Andile Khathi |
| 14 |
[GO] |
2022―Mar―16 |
Diabetic Ketoacidosis (DKA), a Leading Risk Factor for Mucormycosis (Black Fungus), During the Era of Coronavirus Disease-2019 (COVID-19): An Overview |
Nadeem Rais, Rizwan Ahmad, Akash Ved, Kehkashan Parveen, Darakhshan Gazala Bari, Om Prakash |
| 15 |
[GO] |
2022―Feb―25 |
Impact of Diabetes in COVID-19 Associated Mucormycosis and Its Management: A Non-Systematic Literature Review |
Muhammed Rashid, Asha K. Rajan, Girish Thunga, Vishal Shanbhag, Sreedharan Nair |
| 16 |
[GO] |
2022―Feb―10 |
Association Between Statin Use and Poor Outcomes in COVID-19 Patients with Diabetes Mellitus: A Systematic Review |
Jessica Audrey, Wismandari Wisnu, Dicky L. Tahapary |
| 17 |
[GO] |
2022―Jan―19 |
Cytokines in COVID-19 Patients with Diabetes: Systematic Review |
Teena P. George, Salini Scaria Joy, Mohammad Rafiullah, Khalid Siddiqui |
| 18 |
[GO] |
2021―Nov―18 |
Does Insulin Use Worsen the Prognosis of COVID-19 Patients with Type 2 Diabetes Mellitus? A Current Update |
Elvan Wiyarta, Wismandari Wisnu |
| 19 |
[GO] |
2021―Sep―01 |
SARS-COV-2 in type 2 diabetic patients: Possible roles of exercise training as a medicine |
Mehdi Kushkestani, Mohsen Parvani, Yaser Kazemzadeh |
| 20 |
[GO] |
2021―Aug―15 |
Diabetes Mellitus during the Pandemic Covid-19: Prevelance, Pathophysiology, Mechanism, and Management: An updated overview |
Nadeem Rais, Rizwan Ahmad, Akash Ved, Kehkashan Parveen, Tauheed Ishrat, Om Prakash, et al. (+3) Mohd Shadab, Darakhshan Gazala Bari, Nasir Ali siddiqui |
| 21 |
[GO] |
2021―Aug―09 |
The Impact of Deranged Glucose Metabolism and Diabetes in The Pathogenesis and Prognosis of The Novel Sars-Cov-2: A Systematic Review of Literature |
Victor Okoliko Ukwenya, Sunday Aderemi Adelakun, Temiloluwa Adeola Fuwape, Ayotunde Samuel Adeagbo |
| 22 |
[GO] |
2021―Jun―02 |
Fatal Outcomes from COVID-19 in Diabetes Patients and its Management: Impact of Diabetes and Other Comorbidities on COVID-19 |
Suruchi Singh, Pankaj Bhatt, Satish Kumar Sharma, Tejinder Kaur |
| 23 |
[GO] |
2021―Mar―01 |
Integrated Nutritional Supports for Diabetic Patients during COVID-19 Infection: A Comprehensive Review |
A.K. Obidul Huq, Abu Naim Mohammad Bazlur Rahim, S. M. Golam Moktadir, Ielias Uddin, Mohammad Zahidul Manir, Muhammad Abu Bakr Siddique, et al. (+2) Khaleda Islam, Md. Sirajul Islam |
| 24 |
[GO] |
2021―Feb―17 |
Risk Mortality, prevalence, and possible therapeutics to treat diabetic patients infected with nCOVID-19 |
Sumel Ashique, Navjot K Sandhu |
| 25 |
[GO] |
2021―Jan―03 |
Diabetes mellitus and SARS-CoV-2 infection: pathophysiologic mechanisms and implications in management |
Natalia G. Vallianou, Angelos Evangelopoulos, Dimitris Kounatidis, Theodora Stratigou, Gerasimos Socrates Christodoulatos, Irene Karampela, Maria Dalamaga |
| 26 |
[GO] |
2020―Nov―12 |
COVID-19 in People with Diabetes: Perspectives from Saudi Arabia |
Asirvatham Alwin Robert, Mohamed Abdulaziz Al Dawish |
| 27 |
[GO] |
2020―Oct―22 |
COVID-19 in People with Diabetes: Epidemiological Perspectives and Public Health Actions in the Middle East and North Africa (MENA) Region |
Mohamed Abdulaziz Al Dawish, Asirvatham Alwin Robert |
| 28 |
[GO] |
2020―Oct―13 |
Important Role of Relaxation Techniques on Immune Functions, Glycemic Control, and Stress in Diabetic patients with COVID-19: A Review |
Ayman Abdalla Mahmoud Mohamed, Motaz Alawna |
